Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTA elimination backed by Senate Appropriations Chair Mack; hearing questions whether office is essential.

Executive Summary

OTA WORK CAN BE REPLICATED BY OTHER SOURCES, which increases the likelihood of the Office of Technology Assessment's elimination, Senate Appropriations/Legislative Branch Subcommittee Chairman Mack (R-Fla.) contended at a May 26 hearing. Mack noted that the key question in deciding whether to eliminate OTA is whether the information it provides can be supplied by other sources, and he asserted that "the answer is yes." The elimination of OTA is recommended in both the House and Senate budget proposals.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026324

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel